Table 3.
Group1 1988-89 | Group2 1998-99 | Group3 2008-09 | P value | 1 vs 3 | 1 vs 2 | 2 vs 3 | |
(n = 522) | (n = 600) | (n = 600) | |||||
Male | |||||||
Uncontrolled high cholesterol (≥ 240 mg/dL) | 20.80% | 14.30% | 13.9% | 0.002 | < 0.05 | < 0.05 | NS |
Hypercholesterolemia | 20.80% | 16.40% | 21.1% | NS | |||
Treated hypercholesterolaemia | - | 2.50% | 40.8% | 0.000 | |||
Treated to target | - | 84% | 91.0% | 0.000 | |||
Hypercholesterolaemia to target | - | 12.80% | 37% | 0.000 | |||
Female | |||||||
Uncontrolled high cholesterol (≥ 240 mg/dL) | 19.90% | 18.20% | 18.1% | 0.007 | < 0.05 | < 0.05 | NS |
Hypercholesterolemia | 19.90% | 18.90% | 25.8% | NS | |||
Treated hypercholesterolaemia | - | 7.90% | 39.1% | 0.000 | |||
Treated to target | - | 46.70% | 80.2% | 0.000 | |||
Hypercholesterolaemia to target | - | 3.70% | 37% | 0.000 |
Data standardized to the European population; Men and women. Uncontrolled high cholesterol (≥ 240 mg/dL): Subjects with Cholesterolaemia ≥ 240 mg/dL, may or may not have been taking medication; Hypercholesterolemia: Subjects with cholesterol ≥ 240 + cholesterol-lowering therapy subjects; Treated hypercholesterolaemia: Treated/Hypercholesterolemia; Treated to target: Treated to target (cholesterol < 240 mg/dL)/all subjects treated; Hypercholesterolaemia to target: (Hypercholesterolemia < 240 mg/dL/subject with hypercholesterolemia). NS: Non-significant.